Tiansheng Pharmaceutical Group Co Ltd (002872) — Capital Reinvestment Ratio
Tiansheng Pharmaceutical Group Co Ltd (002872) has a Capital Reinvestment Ratio of 0.30x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.79 Million) in capital expenditures (CN¥9.44 Million). See Tiansheng Pharmaceutical Group Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tiansheng Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Tiansheng Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see 002872 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.00x | CN¥50.15 Million | CN¥50.27 Million | ▲ +21.8% |
| 2022 | 0.82x | CN¥89.18 Million | CN¥73.42 Million | ▼ -86.3% |
| 2021 | 6.03x | CN¥18.97 Million | CN¥114.38 Million | ▲ +1134.1% |
| 2020 | 0.49x | CN¥189.75 Million | CN¥92.70 Million | ▼ -24.4% |
| 2019 | 0.65x | CN¥144.21 Million | CN¥93.24 Million | ▼ -57.5% |
| 2018 | 1.52x | CN¥153.99 Million | CN¥234.27 Million | ▲ +81.0% |
| 2016 | 0.84x | CN¥506.68 Million | CN¥425.96 Million | ▼ -34.7% |
| 2015 | 1.29x | CN¥213.54 Million | CN¥274.87 Million | ▼ -25.2% |
| 2014 | 1.72x | CN¥191.99 Million | CN¥330.32 Million | ▼ -22.3% |
| 2013 | 2.21x | CN¥57.06 Million | CN¥126.34 Million | ▲ +74.0% |
| 2012 | 1.27x | CN¥145.06 Million | CN¥184.63 Million | — |